In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters.
Male infertility and the poor quality of sperm seem to be influenced by oxidative stress. In particular, the reactive oxygen species (ROS) mainly produced by morphologically altered spermatozoa affect sperm motility, morphology, and integrity. The aim of this study was to evaluate the efficacy of Myo-Inositol (Myo-Ins) on a number of parameters such as viscosity and total and progressive motility of spermatozoa, in order to better validate its possible practical application in vitro, in order to improve the capacitation protocols commonly used in Assisted Reproductive Technology (ART). A total of 100 fresh and 25 thawed semen samples were analyzed in vitro prior to and after addition of Myo-Ins. Treatment of samples with Myo-Ins showed an increase in the sperm total and progressive motility in both fresh and thawed samples. Furthermore, Myo-Ins proved to be well tolerated by spermatozoa in vitro, demonstrating that it can be efficiently and safely used as antioxidant in the laboratory practice and for preparation of semen samples in ART.
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Mariangela
0000-0001-9919-9205
M
Palmieri
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Palma
P
Papale
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Antonietta
A
Della Ragione
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Giuseppa
G
Quaranta
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Giovanni
G
Russo
Assisted Reproductive Technologies, Clinic Center Hera, Giugliano in Campania, Italy.
Sabatino
S
Russo
Int J Androl. 1994 Dec;17(6):300-7
7744509
Oxid Med Cell Longev. 2008 Oct-Dec;1(1):15-24
19794904
Int J Androl. 2002 Jun;25(3):186-90
12031048
J Anim Sci. 2010 Apr;88(4):1321-31
20042549
Hum Reprod. 1997 Nov;12(11):2434-6
9436679
J In Vitro Fert Embryo Transf. 1990 Jun;7(3):137-40
2380619
Hum Reprod. 1993 Nov;8(11):1948-54
8288765
Fertil Steril. 1979 May;31(5):531-7
446777
Fertil Steril. 2003 Sep;80 Suppl 2:844-50
14505763
Fertil Steril. 2003 Jun;79 Suppl 3:1597-605
12801566
J Reprod Fertil. 1992 Mar;94(2):451-62
1317451
Mol Hum Reprod. 1997 Mar;3(3):175-94
9237244
Am J Public Health. 2004 May;94(5):870-5
15117714
Hum Reprod. 2010 Oct;25(10):2415-26
20716559
J Assist Reprod Genet. 2009 Sep-Oct;26(9-10):537-44
19876730
J Reprod Fertil. 1995 Jan;103(1):17-26
7707295
Fertil Steril. 1992 Feb;57(2):409-16
1735495
Hum Reprod. 1995 Aug;10(8):2061-71
8567843
J Clin Endocrinol Metab. 2006 May;91(5):1968-75
16507629
Indian J Med Res. 2009 Apr;129(4):357-67
19535829
Mol Hum Reprod. 1997 Mar;3(3):169-73
9237243
J Reprod Fertil. 1987 Nov;81(2):459-69
2828610
Reprod Fertil Dev. 2004;16(5):581-8
15367373
Fertil Steril. 1996 Apr;65(4):880-2
8654658
J Reprod Fertil. 1999 Jan;115(1):1-7
10341716
Asian J Androl. 2004 Mar;6(1):59-65
15064836
Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):129-34
21434479
Hum Reprod. 1995 Oct;10 Suppl 1:15-21
8592032
Urology. 2012 Jun;79(6):1290-5
22656408
Antioxid Redox Signal. 2012 Apr 15;16(8):754-9
22149455
Fertil Steril. 2003 Sep;80(3):531-5
12969693
J Androl. 1995 Mar-Apr;16(2):136-42
7559143
Eur Rev Med Pharmacol Sci. 2010 Oct;14(10):891-6
21222378
Fertil Steril. 1992 Dec;58(6):1185-90
1333994